A somewhat random idea for how far-UVC could be productized (once safety and efficacy are more proven out): Couple it with insurance products. (Note I thought about this for maybe 20 min in total, so it is a strong take very weakly held) E.g., sell an insurance against employee sick days (payout per sick day) to employers and install far-UVC in their workplaces as part of the insurance contract. If far-UVC really reduces transmission in offices well enough to warrant the installation costs and provide a benefit on top, this should work out quite well. Most large employers probably have statistics on what sick days cost them each year, so working out a price at which the insurance would be worth taking out could be quite straightforward if one speaks to a few companies (or a consultancy like BCG, Deloitte, McKinsey that sees many organizations). Some reasons I think this would work: There are similar products in the food sector (e.g., Aanika Biosciences sells insurance against recalls of fresh produce that comes coupled with their DNA tags that allow fast and unequivocal identification of produce origin); insurance against employees taking maternity leave is a thing, so employers know this type of model; selling an insurance like that makes the whole sale a topic for high-level HR rather than building management and I suspect there is more purchasing power in the former than the latter.
A somewhat random idea for how far-UVC could be productized (once safety and efficacy are more proven out): Couple it with insurance products.
(Note I thought about this for maybe 20 min in total, so it is a strong take very weakly held)
E.g., sell an insurance against employee sick days (payout per sick day) to employers and install far-UVC in their workplaces as part of the insurance contract. If far-UVC really reduces transmission in offices well enough to warrant the installation costs and provide a benefit on top, this should work out quite well. Most large employers probably have statistics on what sick days cost them each year, so working out a price at which the insurance would be worth taking out could be quite straightforward if one speaks to a few companies (or a consultancy like BCG, Deloitte, McKinsey that sees many organizations).
Some reasons I think this would work: There are similar products in the food sector (e.g., Aanika Biosciences sells insurance against recalls of fresh produce that comes coupled with their DNA tags that allow fast and unequivocal identification of produce origin); insurance against employees taking maternity leave is a thing, so employers know this type of model; selling an insurance like that makes the whole sale a topic for high-level HR rather than building management and I suspect there is more purchasing power in the former than the latter.